^
    Apply
    A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers (NCT05786924)
    Phase 1
    Black Diamond Therapeutics, Inc.
    Recruiting
    Last update posted :
    05/21/2024
    Initiation :
    04/18/2023
    Primary completion :
    06/01/2026
    Completion :
    12/01/2026
    KRAS • BRAF • NRAS
    |
    KRAS mutation • KRAS G12C • BRAF mutation • NRAS mutation • KRAS G12D • KRAS G12V • KRAS G12 • NRAS G12D
    |
    S241656